Keyphrases
Chemotherapy
100%
Lung Cancer
100%
Population-based Study
100%
National Guidelines
100%
Antiemesis
100%
Antiemetic Prophylaxis
75%
Vomiting
50%
Nausea
50%
Substance P
50%
Platinum-based Chemotherapy
50%
Chemotherapy-induced Nausea
50%
Highly Emetogenic
50%
Patient Characteristics
25%
Medicare
25%
Old Age
25%
Economic Outcomes
25%
Lung Cancer Screening
25%
Clinical Outcomes
25%
Radiation Therapy
25%
Logistic Regression
25%
Patient Selection
25%
Multivariate Logistic Regression
25%
Non-adherent
25%
Texas Cancer Registry
25%
American Cancer Society
25%
Linked Database
25%
Clinical Consequences
25%
National Comprehensive Cancer Network
25%
Adherence Rate
25%
Stepwise Selection
25%
Median Income
25%
White Race
25%
Chemotherapy Agents
25%
Logistic Regression Modeling
25%
Medicare Part A
25%
Population Database
25%
Ondansetron
25%
Patient Adherence
25%
Concurrent Radiation
25%
First Diagnosis
25%
Serotonin Antagonists
25%
Economic Consequences
25%
Antiemetics
25%
Antiemetic Agents
25%
Socioeconomic Barriers
25%
Binary Variables
25%
Nursing and Health Professions
Practice Guideline
100%
Lung Cancer
100%
Adherence
100%
Antiemetic Agent
71%
Medicare
28%
Logistic Regression Analysis
28%
Nausea and Vomiting
28%
Substance P Antagonist
28%
Patient Compliance
14%
Malignant Neoplasm
14%
Compliance
14%
Cancer Registry
14%
Cancer Network
14%
Dexamethasone
14%
Chemotherapy Induced Nausea and Vomiting
14%
Serotonin Antagonist
14%
Zofran
14%
Radiotherapy
14%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Lung Cancer
100%
Antiemetic Agent
83%
Malignant Neoplasm
50%
Substance P Antagonist
33%
Nausea and Vomiting
33%
Serotonin Antagonist
16%
Dexamethasone
16%
Chemotherapy Agent
16%
Cancer Registry
16%
Zofran
16%
Chemotherapy Induced Nausea and Vomiting
16%